(UPDATED) Swift initiation of rhythm-control therapy in patients with recently diagnosed atrial fibrillation in the setting of other cardiovascular conditions reduced the risk of CV events as compared ...

Please provide your email address to receive an email when new articles are posted on . In patients younger than 75 years with atrial fibrillation and concomitant CV conditions, an early rhythm ...

The management of patients with atrial fibrillation involves three main areas: anticoagulation, rate control and rhythm control. Importantly, these are not mutually exclusive of each other.

How best to manage nonvalvular atrial fibrillation is controversial. One option is restoring normal sinus rhythm through anti-arrhythmic medications and cardioversion. The rhythm control method ...

Early rhythm control with ablation or antiarrhythmic drugs is associated with a lower risk of adverse cardiovascular outcomes compared with rate control in patients with newly diagnosed atrial ...

Please provide your email address to receive an email when new articles are posted on . A quality improvement initiative raised the proportion of patients with atrial fibrillation who received an ...

Although an early rhythm-control strategy outperformed a primarily rate-control approach for cardiovascular (CV) outcomes in patients with recent-onset atrial fibrillation (AF) in a recent trial, the ...

Patients with atrial fibrillation (AF) benefit from early rhythm control therapy. It reduces cardiovascular deaths, strokes, and other adverse outcomes by 20% compared to usual care. The beneficial ...

A sub-study analysis of the EAST—AFNET 4 trial revealed how genetic risk for atrial fibrillation (AF) and stroke interacts with early rhythm control therapy: Early rhythm control reduces ...

All five trials have shown no improvement in mortality or morbidity by aggressively controlling rhythm with antiarrhythmic drugs. The consistency of these findings is truly remarkable if one considers ...

Typically, management of atrial fibrillation involves pharmacologic or electric maneuvers to convert the patient back to sinus rhythm. Adverse effects from antiarrhythmic drugs and recurrence of ...

To the Editor: The authors of the recently published Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) trial (Dec. 5 issue) 1 conclude that rhythm control offers no advantage ...